Whereas enhancing the LDL-R pathway in the liver is beneficial and antiatherogenic, activating the same pathway in pancreatic beta cells may lead to a harmful cholesterol overload, increased cell death of beta cells and development of diabetes (Roehrich et al., 2003). Here, LDLR is linked to diabetes mellitus.